FYERS
Sun Pharma Advanced Research Company199.47
-3.07 (-1.52%)

Sun Pharma Advanced Research Company Share Price

199.47-3.07 (-1.52%)
+35.86% past 1 Year

News

Sparc narrows quarterly loss as revenue rises sharply

Equity
SPARC
10 Aug 2026

SPARC elevates Anil Raghavan to Managing Director and CEO from August 11

Equity
SPARC
13 Jul 2026

Sparc partner Ocuvex received FDA complete response letter for PDP-716 NDA

Equity
SPARC
19 May 2026

Sparc posts sharp Q4 turnaround with large profit despite revenue decline

Equity
SPARC
18 May 2026

US FDA Approves PRV for Sun Pharma's Seizaby to Treat Neonatal Seizures via SPARC.

Equity
SPARC
30 Apr 2026

Sun Pharma Advanced Research Sells Priority Review Voucher for US $19.50 Crores.

Equity
SPARC
30 Apr 2026

SPARC Reports Q3FY26 Net Loss of Rs 80.60 Crores, Slightly Wider YoY; Revenue Falls to Rs 8.50 Crores.

Equity
SPARC
9 Feb 2026

SPARC Secures US FDA Rare Pediatric Disease Priority Review Voucher for Sezaby Approval.

Equity
SPARC
3 Feb 2026

SPARC Plans Convertible Warrants Issue Up to Rs 600 Crores at Rs 155.80 Each.

Equity
SPARC
14 Jan 2026

SPARC Resubmits Complete Response Letter for PDP-716 NDA to OCuVEX

Equity
SPARC
20 Nov 2025

SPARC merges Mumbai and Baroda R&D labs, consolidating operations into two Baroda sites.

Equity
SPARC
13 Nov 2025

SPARC Q2 FY2026: Net Loss Narrows YoY; Revenue Drops Amid Cost Management Gains

Equity
SPARC
10 Nov 2025

Sparc: Q1 Sl Net Loss 51.90 Crores Rupees Vs Loss 95.90 Crores (Yoy) || Q1 Revenue 9.60 Crores Rupees Vs 16.80 Crores (Yoy)

Equity
SPARC
4 Aug 2025

Sparc: Shares Decrease 19% Following The Failure Of Its Psoriasis Drug In Phase 2 Trials. ???

Equity
SPARC
4 Jun 2025

Sun Pharma Advanced Research: Board Meeting On May 19 To Consider Fund Raising Proposal

Equity
SPARC
12 May 2025

Sun Pharma Advanced Research: Sparc Announces Submission Of Ind Application For Sbo-154 To Usfda || Sbo-154 Set To Enter Global Phase 1 Clinical Trial For Treatment Of Advanced Solid Tumors

Equity
SPARC
31 Mar 2025

Sparc: Q3 Cons Net Loss 79.50 Crores Rupees Vs Loss 99.60 Crores (Yoy) || Q3 Revenue 14.90 Crores Rupees Vs 13.80 Crores (Yoy)

Equity
SPARC
10 Feb 2025

Sun Pharma: Guidance Revision Represents A Cumulative Upside Of ~€45-5.00 Crores From Royalties Over The Next Five Years

Equity
SPARC
14 Jan 2025

Sun Pharma Advanced Research: Co Updates Regarding Asset Developed In Three-Year Partnership Between Co And Ucsf || Co To Receive 55% Equity In Tiller Therapeutics

Equity
SPARC
17 Dec 2024

Sun Pharma Advanced Research: Co Announces Signing Of Binding Loi With Ucsf And Tiller Therapeutics For Pre-Clinical Oncology Asset And Associated Intellectual Property

Equity
SPARC
17 Dec 2024

Sun Pharma Advanced Research Company Ltd Share Price Today

The Sun Pharma Advanced Research Company Ltd share price today is ₹200.30. During the trading session, the Sun Pharma Advanced Research Company Ltd share price opened at ₹199.58 and recorded an intraday high of ₹203.50 and a low of ₹198.50. Last closing price was ₹199.58. Over the past 52 weeks, the Sun Pharma Advanced Research Company Ltd share price has ranged between ₹108.00 and ₹289.00. The current Sun Pharma Advanced Research Company Ltd stock price reflects real-time market activity based on executed trades on the exchange.